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The  technique introduced by Jeme for enumerating  antibody-forming cells 
in agar  (1,  2)  permits precise analysis of the cellular kinetics of the  immune 
response to sheep erythrocytes. In an earlier paper the kinetic events and the 
alterations in  nucleic acid metabolism observed during  the  induction  of  tol- 
erance  to  this  antigen  with  the  immunosuppressive  drug  cyclophosphamide 
were  analyzed  (3).  The  present manuscript  describes the  recovery from  this 
type of tolerance and defines the role of the thymus. 
Methods 
As in the earlier experiments (3), tolerance to sheep erythrocytes was induced in 10-12 wk 
old female CBA mice (Jackson Laboratories, Bar Harbor, Me.) by the intraperitoneal injec- 
tion of 150 or 320 mg/kg of cyclophosphamide  (Cytoxan, Mead Johnson Laboratories, Evans- 
ville, Ind.) in four daily divided doses. The tolerance-inducing  injection of antigen, 0.8 mi of a 
30°/  suspension  (6.4 X  109 cells) of sheep erythrocytes, was injected intravenously immedi- 
ately before the first drug injection. 
The method of Jeme (1, 2),  as previously modified  (3), was employed  to determine the 
number of hemolysin-producing  spleen cells. Animals were challenged  with 0.2 mi of 10% 
sheep cells (5 X  10  s cells) 4 days before sacrifice. An appropriate aliquot of sieved spleen was 
incubated with sheep  erythrocytes in Gey's solution which  was gelled by the  addition of 
Agarose (SeaKem brand obtained from Bausch and Lomb Incorporated, Rochester,  N. Y.). 
The gelled suspension was incubated for 2 hr at 37°C, 1 ml of 1:10 guineapig serum was added, 
and the suspension incubated for an additional hour to develop the direct (19S) plaques. All 
the data presented except for Table I concern 19S plaques, but representative experiments of 
each type were analyzed for indirect (7S) plaques by the addition of rabbit anti-mouse gamma 
globulin serum before the complement addition (3, 4). Unless specified to the contrary, experi- 
mental points are arithmetic means of the spleens of four animals individually plaqued. 
All animals were  subject to postmortem examination,  and the  data from any thymec- 
tomized mice with residual thymus tissue were discarded. Data from operated or nonoperated 
adult animals weighing less than 20 g or with a spleen cell count of less than 100 million were 
also discarded. Such animals usually have pneumonia and respond poorly to sheep cell injec- 
tion. 
* This investigation was supported by Research Grant CA-07179 of the National Cancer 
Institute, United  States Public Health Service and  Grant T-438  of the American  Cancer 
Society. 
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RESULTS 
Decline of Plaque-Forming Cell Response and Thymus Weight with A ge.--Be- 
cause recovery from drug-induced tolerance occupies a considerable fraction of 
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FIG.  1.  Direct hemolytic plaques after challenge and thymus weights of female CBA mice 
of various ages. 
The solid line connects the arithmetic means of hemolytic plaques present in the entire 
spleen 4 days after sheep cell injection. All normal animals of the entire series of experiments 
have been included, the extreme values are represented by vertical bars, and the number of 
animals of each age is indicated in parentheses. 
The broken line connects arithmetic means of thymus weights  (nag)  of groups of three 
animals. 
the life span of the CBA mouse, it was necessary first to establish the variation 
with age of the plaque response to sheep cell injection. Fig. 1 contains a compila- 
tion of the plaque response for all normal animals of various ages in the entire 
series of experiments plotted as plaques per spleen against age. Although there ALAN  C. AIS]~NBERG AND  CAROLINE DAVIS  37 
is wide variation among animals of a given age, the arithmetic means for the 
various ages fall along a smooth curve (the unbroken fine in Fig. 1). This varia- 
tion is decreased, but not eliminated, when animals of different ages are chal- 
lenged and plaqued at the same time (Table I), suggesting that the variability 
is in part due to minor differences in the times between challenge and sacrifice. 
Appreciable numbers of hemolysin-forming cells are not seen after antigenic 
challenge in the 1st wk of life (Fig. 1), appear in the 2nd and 3rd week, rapidly 
rise to a maximum in the 15th to 20th wk, and undergo a substantial decline 
over the remainder of the life of the animal. The spleens of the oldest animals 
studied form only one-third as many plaques in response to antigen as do those 
of mice in their immunological prime. Table I  indicates that the indirect (7S) 
TABLE I 
Direa (19S) and Indirect (7S) Plaques in Mice of Various Ages 
Expt. No.  Age* in weeks  19S Plaques  per spleen  7S Plaques  per spleen 
1  2 
3 
16 
35 
256 
8,740 
137,000 
101,000 
2  1,400 
7  51,900 
18  218,000 
30  81,800 
40  83,800 
5 
14 
28 
42 
54,100 
157,200 
82,700 
54,800 
224 
5,760 
65,000 
73,000 
169,000 
* Age at time of plaquing. 
plaques, which are not plotted in Fig. 1, closely parallel the direct (19S) results 
in animals of various ages. In young animals (2 and 3 wk old), animals in their 
immunological prime (16 and 18 wk old),  and in older animals (35 wk old), in- 
direct plaques were between one-half the number and a number equal to the 
direct plaques 4 days after challenge. 
Fig. 1 also indicates the thymus weights of female CBA mice of various ages 
(broken line). Thymus weight rapidly rises to a maximum in animals 5 wk old 
and then declines. 
Decline  of  Immune  Responsiveness  with  Age in  Thymectomized  Mice.--In 
Table II  the age-related decline of immunity in normal and thymectomized 
mice  is  compared.  The  sheep  cell  response  declines  more  rapidly  in  aging 
thymectomized mice  and  eventually reaches  a  level  25-30%  that  of  non- 38  THYMUS  AND  RECOVERY  FROM  TOLERANCE  TO  SHEEP  ERYTHROCYTES 
operated  animals.  In these  experiments  this ratio was largely reached  20  wk 
after thymectomy, and there was little further disproportionate fall, with sub- 
sequent  aging, in the plaque response of thymectomized mice. 
TABLE II 
Decline of Immune Responsiveness with Age in Tkymectomized Mice* 
Time after  Expt. No.  thyrnectomy  Normal (N)  Thymeet. (T)  Ratio N/T 
1  5 wk 
10 wk 
20 wk 
30 wk 
42 wk 
60 wk 
100 wk 
210,000 
94,700 
94,700 
143,400 
126,000 
73,000 
54,000 
167,000 
63,200 
30,800 
43,200 
36,000 
21,000 
13,700 
0.80 
0.67 
0.30 
0.30 
0.29 
0.29 
0.25 
* Thymectomized at 8 wk of age. 
TABLE HI 
Plaque-Forming Spleen Cells and Total Spleen Cells at Various Times after Cydopkospkamide 
and Cydophosphamide Sheep Cell Administration with and witkout Challenge 
Time 
after 
drug 
18 days 
5 wk 
9 wk 
14 wk 
Antigenic 
challenge 
D 
+ 
+ 
B 
+ 
+ 
Normal 
Plaques  Cells per 
per  spleen 
spleen  X  10  6 
34  135 
93,000  189 
44  157 
64,000  222 
67  224 
290,000  373 
44  141 
191,000  253 
Cyclophosphamide 
Plaques  Cells per 
per  spleen 
spleen  X  10  6 
54  137 
30,300  183 
47  124 
12,800  162 
62  114 
70,000  271 
42  149 
140,000  264 
Cyclophosphamlde 
sheep  ceils 
Plaques  Cells per 
sp~eeern  spleenx  I0' 
2  151 
10  141 
2 
1,190 
16 
41,100 
48 
49,000 
128 
113 
115 
203 
163 
188 
* Cyclophosphamide  80 mg/kg was administered on days i, 2, 3, and 4. 
Recovery  of Plaque-Forming Cells of the  Unstimulated Spleen and of the Pro- 
liferative  Response during Recovery from Tolerance.--Table III lists the number 
of plaques in the spleen 18 days, 5 wk, 9 and 14 wk after cyclophosphamide in an 
experiment in which parallel groups of animals were plaqued without (base line 
plaques)  and  with  antigenic  challenge.  As previously reported  (5),  base  line ALAN  C.  AISENBERG  AND  CAROLINE DAVIS  39 
plaques  are absent 18 days after animals were made completely tolerant to 
sheep  cells by cyclophosphamide  and antigen. These plaques  are still absent 
at 5 wk, begin to return at 9 wk (when mice show partial recovery from tol- 
erance),  and have completely returned at 14 wk (though recovery from tol- 
erance is not complete at this time). This table also indudes the total number 
of spleen cells (counted in a hemocytometer as a conventional white cell count) 
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FIG.  2.  Recovery from tolerance to sheep erythrocytes induced with cyclophosphamide in 
high dosage (80 mg/kg on days 1, 2, 3, and 4). 
•  •,  Normal; O  O, normal, cyclophosphamide; ~, thymectomized, cyclophos- 
phamide; []  [], normal, cyclophosphamide and sheep cells on day 1; W  r  V, thymec- 
tomized, cyclophosphamide sheep  cells. The 18 day and 5 and 10 wk points are arithmetic 
means of 18 animals, the 20 wk point of 9 animals, and the 0, 30, 40 wk points of 6 animals. 
All values are in direct hemolytic plaques per spleen 4 days after challenge with sheep cells. 
before and after antigenic challenge, and it can be noted that specific tolerance 
is accompanied by a loss of the proliferative  response to antigen. 
Recovery from Cyclopkosphamide-Induced Tolerance.--In Fig.  2  data  are 
presented on the disappearance  of tolerance  induced in normal and thymec- 
tomized mice with high dosage cyclophosphamide. This drug dosage results in a 
protracted period of nonspecific immune injury, as indicated by the curve de- 
fined by the open circles. In nonthymectomized, drug-tolerant animals (open 
squares),  some recovery from tolerance is noted at 5 wk, recovery is rapid be- 
tween the 5th and the 14th wk, and much slower improvement continues to the 40  THYMUS  AND  RECOVERY  FROM  TOLERANCE  TO  SHEEP  :E:RYTHROCYTES 
40th wk when the experiment was terminated. Thymectomized, tolerant ani- 
mals (open triangles)  display almost no recovery at 5 wk, a modest recovery 
between 5 and 10 wk, and no subsequent improvement. 
In Fig. 3, identical data (the normal control curve has been omitted) for an 
experiment with low dosage cyclophosphamide are plotted. The results appear 
quite similar to those obtained with the higher drug level, with the exception 
that recovery from nonspecific drug injury is essentially complete at the end of 
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Fro. 3. Recovery from tolerance to sheep erythroeytes induced with cyclophosphamide  in 
low dosage (40 mg/kg on days 1, 2, 3, and 4). Legends the same as Fig. 2, except that the 
points are arithmetic means of 4 animals. 
18 days. Thereafter, the hemolysin-producing cell response in animals treated 
with the drug alone passes through the age-related maximum and decline that 
was described in untreated animals. From the plotted data, it appears that the 
slowly rising curve for animals made tolerant to sheep cells with cyclophos- 
phamide will  cross  the falling cyclophosphamide control curve about 40 wk 
after recovery from tolerance is first observed. As at the higher drag dosage, 
some recovery of specific responsiveness occurs in thymectomized animals in 
the first 10 wk, but none thereafter. It is of considerable interest that thymec- ALAN  C.  AISENBERG AND  CAROLINE  DAVIS  41 
tomy  does not  influence  the  recovery from  the  nonspecific  immunological 
depression induced with either high or low dosage cyclophosphamide (points 
indicated by arrows in Figs. 2 and 3), but only recovery from specific immune 
tolerance. 
The Influence of Delayed Thymectomy on the Recovery  from Tolerance.--It is 
important to determine whether the thymus is required only during the period 
of cellular  repopulafion after drug administration,  or whether the organ must 
be continually present for recovery from tolerance to proceed. Thus the experi- 
ment represented in Table IV contains an additional group of animals in whom 
tolerance was induced with drug and antigen, and who were thymectomized 18 
days later at a time when tolerance was still complete (experimentally verified). 
The recovery of the late thymectomy group can then be compared with non- 
thymectomized animals  and  animals  thymectomized before the induction  of 
TABLE IV 
Effect of Delayed Thymeetoray on Recovery/tom  Tolerance to Sheep Cells 
Induced ugth CyclophospharMde 
Experimental group* 
Normal control 
Tolerant, nonthymectomized 
Tolerant, thymectomized before tolerance is induced 
Tolerant, thymectomized 18 days after tolerance is induced 
Plaques per spleenl: 
180,700  4-  101,000 
22,800  4-  10,200 
4,160  4-  2,030 
2,570  4-  1,130 
* All animals plaqued at 22 wk of age, 10 wk after tolerance was induced with 160 mg/kg 
of cyclophosphamide. 
Groups of 6 animals, -4- standard deviation. 
tolerance. The results indicate that late thymectomy is equally effective in pre- 
venting subsequent immune recovery. 
Indirect Plaques--Representative experiments of each of the previous sections. 
were analyzed for indirect plaques with findings essentially similar to the direct 
results  reported. 
DISCUSSION 
The decline in the immunological  responsiveness  of intact mice with advanc- 
ing age  seen in these  experiments has been observed before (6, 7),  and  the 
more rapid decrease of this responsiveness  seen in thymectomized adult ani- 
mals has been reported by several investigators (7-9). Since it is known (10) 
that thymus weight goes through a maximum in mice 4-6 wk of age (in CBA 
mice the maximum is at 5 wk) after which it diminishes,  it would be important 
to establish whether the decline in this organ is related to the subsequent decline 
in immunological  reactivity. (The observation that the peak of the sheep cell- 42  T~US  AND  RECOVERY  FROM  TOLERANCE  TO S]IEEP ERYTHROCYTES 
plaque response occurs about 10-15 wk after the decrease in thymus weight has 
begun makes it unlikely that the thymus decline is a manifestation of senescence 
of the lymphoid system in general.) In our own work, during the first 20 wk 
after thymectomy, operated mice show a disproportionate fall in immune re- 
sponsiveness reaching a level of 30 %  that of intact animals of the same age. 
Thereafter,  the fall of responsiveness of thymectomized animals parallels or 
slightly exceeds the fall in nonoperated mice. Thus, our data in thymectomized 
animals could be explained as a decline which is a composite of that caused by 
thymectomy and that caused by aging. Our studies neither support nor contra- 
dict Metcalf's view (6), based on his failure to restore the immune response of 
old animals with newborn thymus grafts, that senescence of immune responsive- 
ness in mice is not caused solely by a decline of thymus function. 
Our experiments connect two events with the induction of specific imrm~lo- 
logical tolerance:  the disappearance of hemolysin-producing cells of  the un- 
stimulated spleen (base line plaques), and the loss of the proliferative response 
to antigen. Disappearance with induction, and return with recovery from tol- 
erance are strong evidence that the base line plaque-forming cell is related to 
the cell that responds to antigen. This conclusion does not contradict the find- 
ings of Hege and Cole (11)  that such cells are present in immunologically in- 
competent, neonatally thymectomized mice, or our own data  1 that such cells 
are also present in similarly incompetent thymectomized, irradiated adult CBA 
animals. Although possession of 19S hemolysin-producing cells before antigen 
stimulation is not a  suificient condition for immunological responsiveness, it 
may be a necessary one. It appears that the number of such base line plaques 
is not directly related to the final number of antibody-forming cells produced, 
either during recovery from tolerance in our experiments, or during manipula- 
tions made by others (11),  to alter the number of such base line cells. Finally, 
the  experiments  of  Playfair,  Papermaster,  and  Cole  (12),  which  place  the 
number of precursor  cells  one to two orders of magnitude greater  than the 
number of base line Jerne plaques, should be cited. From the available evidence, 
the Jerne plaque present before antigenic stimulation is related to or derived 
from the ceil that responds to antigen but is not that cell itself. 
It is also of interest that the proliferative response after the injection of sheep 
erythrocytes is lost with the induction of tolerance and returns with recovery. 
This increase in spleen cells seen after antigenic stimulation (0.5  to 1 X  108 
cells) is far greater than the observed increase in plaque-formers (1  to 3 X  105 
cells).  Thus, the proliferative response includes cells either with other types of 
immunological function or without immunological function. However, what- 
ever the function of these cells, under the present experimental conditions their 
proliferation is antigen specific. 
The curve of waning cyclophosphamide tolerance obtained with the plaque 
1  Aisenberg, A. C., and C. Davis. Unpublished observations. ALAN  C.  AISENBERG  AND  CAROLINE  DAVIS  43 
technique is complex. The initial 18 days during which tolerance is complete is 
followed by 10 wk of rapid recovery, followed by a much slower restoration over 
the remaining 20-30 wk of observation.  The entire recovery period evidently 
takes from 40-50 wk. The period of rapid recovery from tolerance corresponds 
to the time of increase in the plaque response of normal and cyclophosphamide 
control ~nimals, and this rapid restitution may be related to the age-dependent 
increase of immune responsiveness. There is a parallel  here with the work of 
Mitchison, who observed that the rate of recovery from erythrocyte tolerance 
in chickens declined with advancing age (13). Whereas Mitchison observed that 
tolerance declined more slowly in groups of older animals, we find that the in- 
cremental recovery from tolerance is less as animals age. If one views recovery 
from tolerance as the repopulation of the lymphoid system with new cells that 
have not been rendered tolerant (14), then it is plausible  that more rapid cell 
proliferation  results in more rapid recruitment of nontolerant cells in younger 
animals. Mitchison has also studied tolerance in mice and finds that it requires 
over 3 months (his data extrapolate to 20 wk)  to induce complete  tolerance 
with low doses of bovine serum albumin (13, 15). The longer time required for 
recovery from drug-induced  tolerance (more than 40 wk in our experiments  as 
compared with 20 wk to induce tolerance in Mitchison's work) may reflect im- 
paired reequipment after drug-induced  injury or other differences in mouse 
strain or antigen. 
The present experiments further clarify the role of the adult thymus. First, 
there can be little doubt that the 19S hemolysin-producing cell of the adult CBA 
mouse is thymus dependent. Recovery from tolerance  proceeds minimally in 
the first 10  wk (the thymectomized animal always lagging behind the non- 
operated one in the degree of recovery),  and then stops.  Thus the ability to 
generate new cells which will respond to this antigen is markedly diminished, 
though neither the actual cellular reconstitution of the drug-depleted spleen nor 
the immune responsiveness of the animal that has received drug w/thout anti- 
gen is impaired by thymectomy. In this connection  our experiments  confirm 
and extend the work of Clamen and Talmage (16) and of Taylor (17) on the 
contribution of the thymus in recovery from tolerance  to protein antigens. 
It had not been expected that removal of the thymus 18 days after inducing 
drug tolerance  would be as effective as immediate thymectomy in preventing 
the recovery from tolerance,  since restoration of the spleen cell population is 
essentially  complete at 18 days. Our work is also at variance with the conclusion 
of Miller et al. (18) that the thymus functions only for the first 7 to 15 days in 
recovery from the immune impairment of lethal irradiation. If current views of 
lymphocyte migration are invoked (i9-21),  marrow cells begin  their transit 
through the thymus and acquire immune competence only some 18 days after 
drug injection.  Our results are equally compatible with a humoral mechanism 
of thymus function (22, 23). 
Unlike  lethal  irradiation  with  bone  marrow,  cyclophosphamide  without 44  ~S  AND  RECOVERY  FROM  TOLERANCE  TO  SItEEP  ERYTtIROCYTES 
antigen cannot eliminate  immunocompetent cells. While  there is a  transient 
nonspecific depression  immediately after drug injection,  this probably repre- 
sents depletion of effector lymphoid cells and is restored in a week or 10 days in 
animals either with or without their thymus. This unreacfivity of drug without 
antigen contrasts sharply with that seen after drug plus antigen, which is spe- 
cific and requires  the thymus for restoration. Treatment with drug (without 
antigen) also contrasts with lethal irradiation (with bone marrow)  which elim- 
inates cells competent to respond to a variety of antigens (including sheep cells 
[footnote 1 and reference 24]) and in which restoration is thymus-dependent. 
Thus drug plus antigen accomplishes the same thing for the specific antigenic 
response  that lethal irradiation (bone marrow)  without antigen accomplishes 
for the responses to a variety of antigens. The conclusion that the target cell is 
the same in the two latter instances appears reasonable. 
SUMMARY 
Recovery from specific  immunological tolerance  to sheep erythrocytcs  in- 
duccd with the drug cyclophosphamide was studied  with the hemolytic plaque 
technique of Jerne.  The base line  plaque (19S  antibody-formlng cell  of the un- 
stimulatcd  spleen)  and the  proliferative  response  to  antigen,  both of  which had 
disappeared during tolerance  induction,  returned with the recovery of specific 
inununological reactivity. 
When cydophosphamide is injected  without sheep ccUs  there  is temporary 
immunological unreactivity  and lymphoid depletion  of the spleen,  but specific 
tolerance  is  not induced.  Recovery is  largely  complete at the end of 2 wk and 
does not require  the  participation  of  the  thymus. 
When cyclophosphamidc is  injected  together  with sheep cells,  18 days after 
drug injection,  tolerance  is  still  complete.  In nonthymcctomlzcd mice there  is 
rapid  recovery  during  the  next 10 wk, followed  by  much slower  restoration  ovcr 
the remaining 20-30 wk of observation.  The entire  recovery  process  evidently 
takes 40-50 wk. In thymectomized CBA  mice only minimal recovery takes 
place  in the first  10 wk and no further  restoration  occurs  thereafter.  Thymec- 
tomy performed 18 days after  tolerance  is  induced,  when tolerance  is  complete, 
is  equally  effective  in  preventing  this  recovery. 
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